The National Pharmaceutical Council (NPC) Board of Directors recently agreed to renew the annual membership in the Institute for Clinical and Economic Review (ICER). This membership renewal is not an endorsement, rather it signifies their commitment to the critical dialogue necessary to ensure appropriate decision regarding future value assessments. Read more here. (Source: NPC, 9/8/16)